Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Industry: Medical Devices
Follow @stockchartsai on TwitterIn the past 30 trading days, PODD has been trading in a range between $187.95 and $127.77 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
PODD is trading between resistance at $223.89 about 15% to the upside and support at $167.38 -14% to the downside. If it can break above the resistance, it could have some more upside to the next line of resistance at $285.53, about a 47% move. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.
Insulet Corporation (PODD) entered a Green zone 18 days ago on the AI powered stock chart. Wall Street analysts have a recent rating of 4.273, which is a Strong Buy. The current analyst target price is $257.94, which gives it a potential upside of 32.59 % from the recent price of 194.54. The stock is trading 72.67% (potential upside) below its 52 week high of $335.91 and 54.62 % (potential downside) above its 52 week low of $125.82 - based on the recent price.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia.
Integra Gains From New Product Launches, Mounting Costs Ail Integra expands the international reach of the CUSA platform and registers DuraGen, DuraSeal, Mayfield and Duo LED lighting in the EMEA and Latin America. Source: Zacks Investment Research Tue, 05 Dec 2023 09:46:08 -0500 Sentiment: Positive |
Top 5 Momentum Picks for December After Rejuvenated November Five momentum stocks for December are: NVDA, VRT, CPRT, CEG, PODD. Source: Zacks Investment Research Mon, 04 Dec 2023 09:02:13 -0500 Sentiment: Neutral |
4 Best Stocks to Invest in for Solid Earnings Growth Invest in stocks such as Insulet (PODD), W.R. Berkley (WRB), Invitation Home (INVH) and VICI Properties (VICI) for superb earnings growth. Source: Zacks Investment Research Mon, 04 Dec 2023 07:31:27 -0500 Sentiment: Positive |
Salesforce, Insulet, and Datadog Are November's Top Performers—and These Are the Worst Salesforce is the Dow Jones Industrial Average's top-performing stock in November, while Cisco is the worst. Source: Barrons Thu, 30 Nov 2023 12:43:00 -0500 Sentiment: Positive |
Insulet to Present at Upcoming Investor Conferences ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at two upcoming investor conferences (all Eastern Time): The Nasdaq 29th Investor Conference in London on Tuesday, December 5, 2023 at 10:00 a.m. The J.P. Morgan Annual Healthcare Conference in San Francisco on Tuesday, January 9, 2024 at 12:45 p.m. To listen to the live audio webcasts. Source: Business Wire Tue, 28 Nov 2023 06:00:00 -0500 Sentiment: Neutral |
Stock Analyzed Each Night
Easily Upload Track Your Stocks
See Lists of Stocks Starting New Trends
The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.